Erectile dysfunction is a disease that affects half of American men aged over 50 years. Many men respond to oral phosphodiesterase inhibitors but many do not. For this reason, many researchers are ...
Erectile dysfunction (ED) is a common condition affecting millions of men worldwide. While traditional treatments, such as medications and surgical methods, offer temporary relief, new advancements in ...
Vybrique is expected to be available in March 2026, with a direct to home delivery option being available to all states. The Food and Drug Administration (FDA) has approved Vybrique ™ (sildenafil) ...
Low-intensity extracorporeal shockwave therapy (Li-ESWT) has attracted growing clinical and commercial interest as a noninvasive drug-free choice for erectile dysfunction (ED). Despite a mounting body ...
Credit: Haleon. The OTC gel is applied to the penis just before sex and has an onset of action of 10 minutes. Eroxon ®, an over-the-counter (OTC) topical treatment for erectile dysfunction (ED) will ...
In some people with kidney stones, low-intensity shockwave therapy (LIST) breaks them up. And in some with heart disease and fractures, LIST coaxes the body to produce new blood vessels that help with ...
Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...
Research suggests that obesity and obesity-related diseases are potential causes of erectile dysfunction (ED). In these cases, losing weight may help improve erectile function. Erectile dysfunction is ...
Young Americans are facing a stiff problem in the bedroom. Across the country, a growing number of men in their sexual prime are struggling with erectile dysfunction — and leaning on prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results